VHCP Management II

Latest statistics and disclosures from VHCP Management II's latest quarterly 13F-HR filing:

Companies in the VHCP Management II portfolio as of June 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Avexis 30.74 1.04M 74.31
Biohaven Pharmaceutical Holding 15.15 NEW 1.66M 22.79
Ascendis Pharma A S 10.94 +21% 986492 27.76
Edge Therapeutics 7.92 1.93M 10.26
Dbv Technologies 7.56 373617 50.68
Ra Pharmaceuticals 5.76 +6% 769771 18.74
BioCryst Pharmaceuticals (BCRX) 5.50 -59% 2.48M 5.56
Argenx Se 5.44 NEW 647015 21.04
Axovant Sciences 2.79 -29% 301718 23.19
Acceleron Pharma 1.90 156880 30.39
Cytomx Therapeutics 1.79 288915 15.50
ARCA biopharma (ABIO) 1.03 1.08M 2.40
Akari Therapeutics 0.78 +15% 426297 4.61
Kalvista Pharmaceuticals 0.65 221651 7.36
Lipocine 0.62 -7% 386928 4.02
Ocera Therapeutics 0.56 1.22M 1.16
Obseva Sa 0.51 NEW 150000 8.55
Adverum Biotechnologies 0.28 280000 2.50
Sierra Oncology 0.06 130798 1.17

Past 13F-HR SEC Filings by VHCP Management II

View All Filings